373P Brain metastases: Extracranial disease status as a prognostic factor after whole brain radiotherapy. Results from a prospective, population-based study von Yri, O.E., Astrup, G.L., Hjermstad, M.J., Aass, N.K., Lund, J-Å., van Helvoirt, R., Paulsen, Ø., Kaasa, S.

Volltext

1441O Patient-reported outcomes in cancer patients newly diagnosed with brain metastases von Astrup, G.L., Kaasa, S., Aass, N.K., Hjermstad, M.J., Lundeby, T., van Helvoirt, R., Lund, J-Å., Paulsen, Ø., Yri, O.E.

Volltext

282MO Brain metastases: Real-life treatment patterns, survival and patient-reported outcomes – Results from a population-based, prospective study in 914 patients von Yri, O.E., Astrup, G.L., Karlsson, A.T., Paulsen, Ø., Van Helvoirt, R., Lund, J-Å., Taran, M-I., Jensen Hjermstad, M., Birketvedt, M., Bjerkeset, E., Aass, N., Kaasa, S.

Volltext

1592MO Anticancer therapy at the end-of-life: A cluster-randomized trial von Hjermstad, M.J., Pirnat, A., Aass, N., Andersen, S., Astrup, G.L., Dajani, O., Garresori, H., Guldhav, K.V., Hamre, H.M., Haukland, E.C., Jordal, F., Lohre, E.T., Lundeby, T., Mjaaland, S., Paulsen, Ø., Semb, K.A., Staff, E.S., Wester, T.E., Kaasa, S.

Volltext